コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 essful sites of deep brain stimulation (DBS; essential tremor).
2 (4 mm anterior and 3 mm superior to that for essential tremor).
3 c acid tone seems to be a central feature of essential tremor.
4 ing an important role in the pathogenesis of essential tremor.
5 in stimulation pulses are delivered to treat essential tremor.
6 n of the thalamus can help ameliorate severe essential tremor.
7 s in the Purkinje cell axonal compartment in essential tremor.
8 h clinical diagnostic error rates for PD and essential tremor.
9 patients with severe, medication-refractory essential tremor.
10 ges and cell death deserves further study in essential tremor.
11 ultrasound thalamotomy for the treatment of essential tremor.
12 s: Parkinson's disease, primary dystonia and essential tremor.
13 tructural abnormalities in the brain such as essential tremor.
14 ceptor antagonist, can trigger or exacerbate essential tremor.
15 and potential targets for pharmacotherapy of essential tremor.
16 nt findings of mild olfactory dysfunction in essential tremor.
17 innervation, as did the member with isolated essential tremor.
18 most common causes are Parkinson disease and essential tremor.
19 the primary motor cortex in individuals with essential tremor.
20 thmic motor drive responsible for generating essential tremor.
21 suffer from postural tremor, consistent with essential tremor.
22 include Lewy body dementia and some forms of essential tremor.
23 ng tremor, but not in Parkinson's disease or essential tremor.
24 were significantly improved in patients with essential tremor.
25 disorders, including Parkinson's disease and essential tremor.
26 their patterns and diagnose diseases such as essential tremor.
27 cted from control subjects and patients with essential tremor.
28 olivocerebellum determines the frequency of essential tremor.
29 eep brain stimulation for some patients with essential tremor.
30 short-term memory system in the diagnosis of essential tremor.
31 ffective treatment for medication refractory essential tremor.
32 effective treatment for medically refractory essential tremor.
33 inform targeting and programming in DBS for essential tremor.
34 dementia, Parkinson's disease, and probable essential tremor.
35 nt disorders such as Parkinson's disease and Essential Tremor.
36 with tremor improvement in both dystonic and essential tremor.
37 ndent stimulation of the cerebellum to treat essential tremor.
38 r-cognitive interactions in individuals with essential tremor.
39 patient-specific therapeutic approaches for essential tremor.
40 years) who underwent DBS in the treatment of essential tremor.
41 disorders, including Parkinson's disease and essential tremor.
42 erapeutic modality that can be used to treat essential tremor.
43 ase and the ventral intermediate nucleus for essential tremor.
44 ctivity in patients with dystonic tremor and essential tremor.
45 overdiagnosis of well-known causes, such as essential tremor.
46 reatest alpha desynchronization occurring in essential tremor.
47 history studies show a high heritability for essential tremor.
48 al coactivator PPARGC1A were associated with essential tremor.
49 LINGO1) did not confirm the association with essential tremor.
50 safety and efficacy of DBS in patients with essential tremor.
51 ould be of importance in the pathogenesis of essential tremor.
52 s with the degree of clinical improvement in essential tremor.
56 conducted a genome-wide association study of essential tremor, a common movement disorder characteriz
57 on's disease, obsessive-compulsive disorder, essential tremor, addiction, pain, minimally conscious s
59 phere, as the primary generator of tremor in essential tremor, also with a significant contribution o
60 nucleus of the thalamus in 29 patients with essential tremor and 24 patients with Parkinson's diseas
61 erebellar cortical tissue from 27 cases with essential tremor and 27 age-matched control subjects was
62 f the Purkinje cell axonal compartment in 49 essential tremor and 39 control brains, using calbindin
63 ebellar syndrome (multiple sclerosis, n = 3; essential tremor and ataxia, n = 1), although clinical t
64 is a standard of care in Parkinson disease, essential tremor and dystonia, and is also under active
65 tudy explored the optimal targets for DBS in essential tremor and dystonic tremor using a combination
66 h Parkinson's disease, in four subjects with essential tremor and in none of the subjects with psycho
67 ations for understanding the pathogenesis of essential tremor and its relationship to Parkinson disea
69 This review will consider Parkinson disease, essential tremor and other tremors and highlight advance
70 en Food and Drug Administration-approved for essential tremor and Parkinson disease and has a humanit
73 ion consanguineous Turkish kindred with both essential tremor and Parkinson disease, we carried out w
76 phy to discriminate Parkinson's disease from essential tremor and Parkinsonism, the involvement of no
77 ures of dystonic tremor can resemble that of essential tremor and present a diagnostic confound for c
78 rentiating parkinsonian syndromes (PS), from essential tremor and probable dementia with Lewy bodies
79 rs substantially between dystonic tremor and essential tremor and should be further explored in imple
80 Accordingly, we stimulated 10 patients with essential tremor and thalamic electrodes, while recordin
81 HTRA2 p.G399S is responsible for hereditary essential tremor and that homozygotes for this allele de
84 roup of male and female subjects affected by essential tremor and undergoing deep brain stimulation s
85 ibrillation, occlusion of cerebral arteries, essential tremor, and abnormal reflexes were not signifi
86 the tapping limb in Parkinson's disease and essential tremor, and its frequency in many cases shifte
87 nts than Parkinson's disease rest tremor and essential tremor, and its frequency was less consistent.
88 uggest an association between blood lead and essential tremor, and that this association is modified
89 disease and 20 postural tremor recordings in essential tremor, and validated on a second, independent
90 neuronal and EMG activities during intention essential tremor are similar to those of the intention t
93 n the efficacy of neurosurgical treatment of essential tremor, are in contrast to those of previous s
96 ern regarding the potential risks of certain essential tremors associated with the long-term, low-lev
98 a safe and effective therapy for refractory essential tremor, but information regarding long-term ou
99 y of focused ultrasound (FUS) thalamotomy in essential tremor, but its effectiveness and safety for m
100 atterns of dopamine and serotonin release in essential tremor, but not Parkinson's disease, patients.
101 erves, have also been developed for treating essential tremor, but the clinical outcomes remain incon
102 nificant tremor suppression in patients with essential tremor, but with significant inter-patient var
104 t that subjects with Parkinson's disease and essential tremor can produce movements that are kinemati
105 , the dendritic spine density was reduced in essential tremor cases (medians=0.82 versus 1.02 microm(
106 climbing fibre-Purkinje cell synapses of 12 essential tremor cases and 13 age-matched controls from
109 We observed that, compared with controls, essential tremor cases had decreased climbing fibre-Purk
114 d were correlated with tremor duration among essential tremor cases with age of onset >40 years.
116 o hundred one essential tremor brains in the Essential Tremor Centralized Brain Repository underwent
118 n Purkinje cells have been identified in the essential tremor cerebellum, although the mechanisms tha
124 ith medication-refractory dystonic tremor or essential tremor, deep brain stimulation (DBS) targeting
125 remor suppression) in selected patients with essential tremor despite delivering less than half the e
129 mon hyperkinetic movement disorders, namely, essential tremor, dystonia, Huntington disease and other
130 for conditions such as Parkinson's disease, essential tremor, dystonia, obsessive-compulsive disorde
131 ts and task prioritization in 15 people with Essential Tremor (ET) and 15 age-matched people without
133 d ultrasound (MRgFUS) thalamotomy lesions in essential tremor (ET) and tremor-dominant Parkinson dise
136 undergoing deep brain stimulation (DBS) for essential tremor (ET) from 5 different European centers
151 Materials and Methods Participants with essential tremor (ET) or Parkinson disease (PD) undergoi
152 cted from DBS surgical instruments in PD and essential tremor (ET) patients and demonstrate that alph
153 We screened 662 subjects comprising 462 essential tremor (ET) subjects (285 sporadic, 125 with f
154 e aberrant neural oscillation that hallmarks essential tremor (ET) syndrome, the most common adult mo
155 ese patients with that seen in patients with essential tremor (ET) using two neurophysiological techn
156 tures, which show selective vulnerability in essential tremor (ET), a cerebellar degenerative disorde
163 mmon symptom of Parkinson's disease (PD) and essential tremor (ET), which affects manual targeting, m
171 lence of and conversion rates to dementia in essential tremor fall between those associated with the
172 recent attention to cognitive impairment in essential tremor, few studies examine rates of conversio
176 ced by low frequency thalamic stimulation in essential tremor has a narrower frequency-amplitude tole
177 termedius nucleus deep brain stimulation for essential tremor has been the loss of surgical efficacy
178 g disorders, such as Parkinson's disease and essential tremor, has encouraged its application to a wi
179 Surgical therapies are effective in reducing essential tremor, however, the invasive nature of these
181 rformance for Parkinson's disease tremor and essential tremor, in both test and validation datasets.
186 rders including Parkinson's disease (PD) and essential tremor is determined through clinical assessme
189 our data suggest that the pathophysiology of essential tremor is primarily attributable to the abnorm
192 ease of the cerebellum or cerebellar system; essential tremor may be neurodegenerative; low gamma ami
193 hat the effects of electrical stimulation on essential tremor may be phase dependent, and that, in pa
195 Existing studies suggest that pathology in essential tremor might emerge from multiple cortical and
197 , only ventrolateral thalamic stimulation in essential tremor modulated postural tremor amplitude acc
198 c to Parkinson's disease, but also occurs in essential tremor, most prominently for the coupling of a
200 subjects with Parkinson's disease (n = 20), essential tremor (n = 8) and psychogenic tremor (n = 7).
201 ects with Parkinson's disease (n = 11), with essential tremor (n = 9) and without a movement disorder
202 nts had a history of either isolated tremor (essential tremor, n = 2; benign tremulous Parkinson's di
203 rd treatment for laryngeal dystonia (LD) and essential tremor of the vocal tract (ETVT) is botulinum
204 urodegeneration such as Alzheimer's disease, essential tremor or drug-induced parkinsonism and hence
206 S surgeries in 25 human patients with either essential tremor or Parkinson's disease, we acutely reco
208 .0312; ventrolateral thalamic stimulation in essential tremor, P=0.0137; two-tailed paired Wilcoxon s
211 kers for conversion from essential tremor to essential tremor-Parkinson's disease would be of conside
212 and connectivity between dystonic tremor and essential tremor patient cohorts to better understand di
213 nt drug therapies that alleviate symptoms in essential tremor patients (primidone, propranolol, and g
217 tion-induced worsening of intelligibility in essential tremor patients with bilateral thalamic deep b
224 h a clinical diagnosis of PS, non-PS (mainly essential tremor), probable DLB, and non-DLB (mainly Alz
225 eatment efficacy with the Quality of Life in Essential Tremor Questionnaire (ranging from 0 to 100%,
227 je cell dendritic architecture and spines in essential tremor relative to control brains provides add
231 ly of diseases rather than a single disease; essential tremor seems to be a disease of the cerebellum
232 arkinson's disease and in all four remaining essential tremor subjects but in none of the psychogenic
233 and encourage research into the creation of essential tremor subsets that are defined with respect t
234 ter in subjects with Parkinson's disease and essential tremor than in subjects without a movement dis
236 mbles other common tremor disorders (such as essential tremor) that occur in patients who have an oth
237 ogram at tremor frequencies suggests that in essential tremor the tremor is imposed on the active mus
239 cardinal feature of Parkinson's disease and essential tremor, the two most common movement disorders
240 tifying clinical markers for conversion from essential tremor to essential tremor-Parkinson's disease
241 ow of ideas from clinical observations about essential tremor, to their translation into scientific s
242 date of patients with Parkinson's disease or essential tremor undergoing deep brain stimulation surge
243 e ventralis intermedius thalamic nucleus for essential tremor underwent functional magnetic resonance
244 k contralateral motor score improvement, for essential tremor was located in the ventral intermediate
246 of abnormalities in Purkinje cell biology in essential tremor, we hypothesized that regressive change
247 rmometry) data acquired during treatments of essential tremor, we verified that our simulation framew
251 sent, 15 patients with medication-refractory essential tremor were enrolled in a HIPAA-compliant pilo
252 ted with the primary sensorimotor regions in essential tremor, whereas in dystonic tremor, the correl
253 variability of SCN4A with the development of essential tremor, which adds ET to the growing list of n
254 ase functional independence in patients with essential tremor, who exhibit both mobility and cognitiv
255 Such differences in parkinsonian rest and essential tremor will be important in selecting future s
256 es were able to classify dystonic tremor and essential tremor with 89% area under the curve, whereas
258 cal diagnoses were essential tremor (93.5%), essential tremor with possible Parkinson's disease (3.5%
259 ents, age: 50-77 years) and 10 patients with essential tremor with thalamic electrodes (nine male and
260 tnessed a remarkable increase in research on essential tremor, with consequent advances in our unders
261 cortical activity in Parkinson's disease and essential tremor, with the greatest high-beta desynchron
262 tions in functional connectivity compared to essential tremor within higher-level cortical, basal gan
264 >100 Hz, commonly used for parkinsonism and essential tremor, worsened incoordination, and frequenci